Literature DB >> 14595380

Imaging the spatial distribution of transgene expression in the lungs with positron emission tomography.

J-C Richard1, P Factor, L C Welch, D P Schuster.   

Abstract

This study was designed to evaluate the utility of positron emission tomography (PET) to quantify the magnitude and spatial distribution of transgene expression after different methods of adenoviral vector delivery (with surfactant- and saline-based vehicles) within rat lungs. In all, 17 animals (eight in the surfactant group, nine in the saline group) were studied 3 days after intratracheal administration of a replication-incompetent adenovirus encoding a mutant Herpes simplex virus-1 thymidine kinase (mHSV1-TK)-enhanced green fluorescent protein fusion gene driven by a Cytomegalovirus promoter (Ad-CMV-mNLS-HSV1sr39tk-egfp). PET images were obtained 1 h after i.v. administration of 9-(4-[(18)F]-fluoro-3-hydroxymethylbutyl)guanine ([(18)F]-FHBG), an imaging substrate for mHSV1-TK. Overall, the average lung concentration of [(18)F]-FHBG was significantly greater in the surfactant group than in the saline group (0.24+/-0.06 versus 0.17+/-0.03% injected dose/ml lung, P< or =0.05). Lung [(18)F]-FHBG distribution was more peripheral and more homogeneous in the surfactant group than in the saline group (mean coefficient of variation=31+/-4 versus 36+/-3%, respectively, P< or =0.05). Regions of increased tracer concentration in the surfactant group compared to the saline group were evenly distributed throughout the lungs. We conclude that PET imaging provides useful and meaningful information about the effectiveness of different gene transfer delivery strategies within the lungs, and that surfactant-based vehicles may be a superior strategy for pulmonary gene transfer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595380     DOI: 10.1038/sj.gt.3302117

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  7 in total

1.  Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivo.

Authors:  Deming Gou; Telugu Narasaraju; Narendranath Reddy Chintagari; Nili Jin; Pengcheng Wang; Lin Liu
Journal:  Nucleic Acids Res       Date:  2004-09-27       Impact factor: 16.971

Review 2.  Molecular imaging of pulmonary gene expression with positron emission tomography.

Authors:  Sekhar Dharmarajan; Daniel P Schuster
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor.

Authors:  Mai Johnson; Breanne D W Karanikolas; Saul J Priceman; Russell Powell; Margaret E Black; Hsiao-Ming Wu; Johannes Czernin; Sung-Cheng Huang; Lily Wu
Journal:  J Nucl Med       Date:  2009-04-16       Impact factor: 10.057

4.  Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury.

Authors:  Ravi Alluri; Hilliard L Kutscher; Barbara A Mullan; Bruce A Davidson; Paul R Knight
Journal:  J Vis Exp       Date:  2017-02-26       Impact factor: 1.355

5.  Imaging and therapy of hSSTR2-transfected tumors using radiolabeled somatostatin analogs.

Authors:  Zhe Wang; Wenhui Ma; Jing Wang; Jinglan Deng; Menghui Yuan; Mingxuan Zhao; Lintao Jia; Weidong Yang; Rui Zhang; Weiwei Qin; Dake Chu; Guoquan Li
Journal:  Tumour Biol       Date:  2013-04-19

6.  Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate.

Authors:  Kenneth N Barton; Hans Stricker; Stephen L Brown; Mohamed Elshaikh; Ibrahim Aref; Mei Lu; Jan Pegg; Yingshu Zhang; Kastytis C Karvelis; Farzan Siddiqui; Jae Ho Kim; Svend O Freytag; Benjamin Movsas
Journal:  Mol Ther       Date:  2008-08-19       Impact factor: 11.454

7.  Three-Dimensional Imaging of the Intracellular Fate of Plasmid DNA and Transgene Expression: ZsGreen1 and Tissue Clearing Method CUBIC Are an Optimal Combination for Multicolor Deep Imaging in Murine Tissues.

Authors:  Shintaro Fumoto; Koyo Nishimura; Koyo Nishida; Shigeru Kawakami
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.